Valuation: BioHarvest Sciences Inc.

Market Cap 41.94M 36.34M 34.29M 31.11M 58.36M 4.02B 58.78M 410M 158M 2.04B 158M 154M 6.48B P/E 2026 *
-3.51x
P/E 2027 * -5.52x
Enterprise Value 41.94M 36.34M 34.29M 31.11M 58.36M 4.02B 58.78M 410M 158M 2.04B 158M 154M 6.48B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.85x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
1 day-2.16%
1 week+0.55%
Current month-4.71%
1 month-12.08%
3 months-46.15%
6 months-60.18%
Current year-64.93%
1 week 1.8
Extreme 1.8
2.05
1 month 1.8
Extreme 1.8
2.63
Current year 1.8
Extreme 1.8
6.15
1 year 1.8
Extreme 1.8
12.8
3 years 0
Extreme 0.0011
12.8
5 years 0
Extreme 0.0011
17.5
10 years 0
Extreme 0.0011
67.9
Manager TitleAgeSince
Chief Executive Officer 68 29/04/2026
Director of Finance/CFO - 28/10/2024
Chief Operating Officer 65 19/04/2023
Director TitleAgeSince
Chairman 68 27/09/2018
Director/Board Member 67 27/09/2018
Director/Board Member 84 07/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
16/3/26 Option 35,049 0.1547%
16/3/26 Other

Chief Operating Officer

0 0%
16/3/26 Option

Chief Executive Officer

43,841 0.1935%
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%+0.55%-79.96%-62.59% 41.94M
+0.71%-0.51%-13.95%-4.41% 13.4B
+0.73%-2.36%-33.00%-56.70% 4.78B
+1.37%-4.28%-4.54%-4.70% 4.36B
+1.25%-3.09%-10.58%-30.50% 3.78B
+0.29%-3.70%-25.45%+1.79% 3.43B
+2.46%-1.28%-1.97%-2.04% 3.41B
-0.07%-4.89%-13.78%+4.32% 3.12B
+1.11%-1.55%-23.77%-16.93% 2.27B
+0.05%-2.76%-29.76%-19.88% 1.63B
Average +0.57%-1.98%-23.68%-19.16% 4.02B
Weighted average by Cap. +0.88%-1.77%-16.10%-13.10%

Financials

2026 *2027 *
Net sales 37.42M 32.42M 30.6M 27.76M 52.07M 3.59B 52.45M 365M 141M 1.82B 141M 137M 5.78B 49.59M 42.97M 40.55M 36.79M 69.01M 4.75B 69.51M 484M 187M 2.41B 186M 182M 7.67B
Net income -12.02M -10.41M -9.83M -8.92M -16.73M -1.15B -16.85M -117M -45.23M -584M -45.14M -44.15M -1.86B -7.65M -6.63M -6.25M -5.67M -10.64M -733M -10.72M -74.69M -28.78M -372M -28.73M -28.09M -1.18B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
89
Date Price Change Volume
15/09/26 USD 1.820 -1.62% 11,752
11/09/26 USD 1.850 -1.07% 28,347
10/09/26 USD 1.870 +3.89% 13,761
09/09/26 USD 1.800 -0.55% 36,810
08/09/26 USD 1.810 -0.55% 27,247
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.850USD
Average target price
10.50USD
Spread / Average Target
+467.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BHST Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!